The subject invention provides advantageous new salts of mu-opiate receptorpeptides. These salts have been found to have excellent properties in terms oftheir crystal structure, stability, solubility, lack of impurities and/orthe ability to be produced, with these advantageous properties, in amounts sufficientfor the production of therapeutic compositions.
